gip/glp-1 drugs The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1 Medications for Weight Loss:

doi: 10.4158/EP161365.GL 25 YumukVTsigosCFriedMSchindlerKBusettoLMicicDet al

Acknowledgements This project is supported by the National Natural Science Foundation of China (NSFC), 52273197 (B.Z.T.) and 52333007 (Z.Z.), National Key Research and Development Program of China, 2023YFB3810001 (Z.Z.), China Postdoctoral Science Foundation, 2023M733423 (W.-J.W.), Shenzhen Key Laboratory of Functional Aggregate Materials, ZDSYS20211021111400001 (B.Z.T.), the Science, Technology and Innovation Commission of Shenzhen Municipality, KQTD20210811090142053 (B.Z.T.), JCYJ20220818103007014 (B.Z.T.), GJHZ20210705141810031 (Z.Z.) and JCYJ2021324134613038 (Z.Z.), Shenzhen Medical Research Fund, A2403004 (W.-J.W.), and Longgang District Medical Key Discipline Construction Found (R.H.)

Figure 4: Changes in body weight in A) lean mice and B) obese mice and changes in food intake in C) lean mice and D) obese mice, across the three different experimental treatment groups

While MIC B12 shots are generally considered safe when administered under the supervision of a qualified healthcare provider, some individuals may experience mild side effects